The newer fluoroquinolones
- PMID: 21679792
- DOI: 10.1016/j.mcna.2011.03.006
The newer fluoroquinolones
Abstract
Clinicians have enthusiastically used fluoroquinolones owing to their good safety profile and wide range of indications. This article reviews fluoroquinolone pharmacology, pharmacodynamic principles, and fluoroquinolone resistance mechanisms, highlighting recent trends in the epidemiology of fluoroquinolone resistance among gram-negative organisms and Streptococcus pneumonia. Important fluoroquinolone safety concerns are discussed, along with indications for the most commonly used fluoroquinolones--ciprofloxacin, levofloxacin, and moxifloxacin.
Copyright © 2011 Elsevier Inc. All rights reserved.
Republished from
-
The newer fluoroquinolones.Infect Dis Clin North Am. 2009 Dec;23(4):1027-51, x. doi: 10.1016/j.idc.2009.06.003. Infect Dis Clin North Am. 2009. PMID: 19909896 Review.
LinkOut - more resources
Full Text Sources
